UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
(Check
One):
|
o
Form 10-K and
Form 10-KSB
|
o
Form 20-F
|
o
Form 11-K
|
|
|
|
x
Form 10-Q and
Form 10-QSB
|
o
Form N-SAR
|
For
Period Ended: April 30, 2005
|
o
Transition Report on Form
10-K
|
o
Transition Report on Form
10-Q
|
|
|
o
Transition Report on Form
20-F
|
o
Transition Report on Form
N-SAR
|
|
|
o
Transition Report on Form
11-K
|
For
the Transition Period Ended: ________________________
Read
attached instruction sheet before preparing form. Please print or
type.
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If
the notification related to a portion of the filing checked above, identify
the
item(s) to which the notification relates:
PART
I
REGISTRANT
INFORMATION
Full
name of registrant: Xenomics,
Inc.
Former
name if applicable: ___________________________________________
Address
of principal executive office (street and number): 420
Lexington Avenue, Suite 1701
City,
state and zip code: New York, New York 10170
PART
II
RULE
12b-25 (b) and (c)
If
the subject report could not be filed without unreasonable effort or expense
and
the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be
completed. (Check box if appropriate.)
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could
not
be eliminated without unreasonable effort or expense.
|
|
|
x
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form
10-K,
20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before
the fifteenth calendar day following the prescribed due date; or
the
subject quarterly report or transition report on Form 10-Q or portion
thereof will be filed on or before the fifth calendar day following
the
prescribed due date; and
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c)has been
attached if applicable.
|
PART
III
NARRATIVE
State
below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR
or
the transition report portion thereof could not be filed within the prescribed
time period.
The
Company’s Quarterly Report on Form 10-QSB for the three months ended April 30,
2005 cannot be filed within the prescribed time period because the Company
requires additional time for compilation and review to insure adequate
disclosure of certain information required to be included in the Form 10-QSB.
The Company’s Quarterly Report on Form 10-QSB will be filed on or before the
5th
calendar day following the prescribed due date.
2
PART
IV
OTHER
INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this notification:
|
||
|
Bernard
F. Denoyer, Vice President, Controller, 212-297-0808
|
|||
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of
the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that
the registrant was required to file such report(s) been filed? If
the
answer is no, identify report(s)
|
||
|
x
Yes
|
o No
|
||
|
(3)
|
Is
it anticipated that any significant change in results of operations
from
the corresponding period for the last fiscal year will be reflected
by the
earnings statements to be included in the subject report or portion
thereof?
|
||
|
|
x
Yes
|
o
No
|
|
If
so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reason why a reasonable estimate
of the results cannot be made.
Xenomics,
Inc.'s financial statements for the three months ended April 30, 2005 to be
included in Xenomics's Form 10-QSB for the three months ended April 30, 2005
will reflect (i) $296,646 of research and development expense and (ii) $628,159
of general and administrative expense.
Xenomics,
Inc.'s financial statements for the three months ended April 30, 2005 to be
included in Xenomics' Form 10-QSB for the three months ended April 30, 2005
will
reflect consolidated loss from operation of $924,804 as compared to a loss
of
$2,820 for the three months ended April 30, 2004.
|
Xenomics,
Inc.
|
|
|
|
(Name
of Registrant as specified in
Charter)
|
has
caused this notification to be signed on its behalf by the undersigned thereunto
duly authorized.
| Date: June 14, 2005 | By: | /s/ Bernard F. Denoyer |
|
|
||
|
Bernard
F. Denoyer
Vice
President, Controller
|
||
3